Share-Based Compensation Plans

3 Months Ended

Jan. 31, 2021

Share-based Payment Arrangement [Abstract]

For the three months ended January 31, 2021 and February 2, 2020, the Company recognized share-based compensation expense of $0.2 million, and $0.5 million, respectively. These expenses are included in Selling, administrative and other operating costs in the Company’s Condensed Consolidated Statements of Operations.

Fiscal 2020 Awards

During fiscal 2020, the Company granted restricted stock units (“RSUs”) to executive management and, due to limited share availability under its long-term incentive plan, issued deferred cash awards to certain employees including executive management. The RSUs and cash awards vest in equal annual tranches over three years, provided the employees remain employed with the Company on the applicable vesting date. The grant date fair value for the RSUs is measured using the closing stock price on the grant date and the total grant date fair value was $0.7 million. The deferred cash awards totaled $2.2 million. In addition, due to limited share availability, cash payments in the aggregate amount of $0.4 million were made in lieu of equity awards to non-executive directors of the Company.

Fiscal 2019 Awards

During fiscal 2019, the Company granted performance stock units (“PSUs”) to executive management, RSUs to certain employees including executive management and its annual equity grant of RSUs to the Board of Directors.

The PSUs are eligible to vest in three equal tranches at the end of each performance period. Vesting of the PSUs is dependent on the achievement of the adjusted Earnings Before Interest, Taxes, Depreciation and Amortization margin percentage goals based on adjusted revenues at the end of each fiscal year of the one-year, two-year and three-year performance periods and provided that the

employees remain employed with the Company on the applicable vesting date. The payout percentages can range from 0% to 150%. The RSUs for the employees vest in equal annual tranches over three years, provided the employees remain employed with the Company on the applicable vesting date. The RSUs for the Board of Directors vested one year from the grant date provided that the director provides continued service through the vesting date. The grant date fair value for the PSUs and RSUs is measured using the closing stock price on the grant date. The PSUs and RSUs had a total grant date fair value of approximately $1.2 million and $2.1 million, respectively.

Summary of Equity and Liability Awards

The following tables summarize the activities related to the Company’s share-based equity and liability awards for the three months ended January 31, 2021:


Performance Share Units	Number of	Weighted Average
	Shares	Grant Date Fair Value




Outstanding at November 1, 2020	209,662	$3.91
Forfeited	(15,245)	$4.04
Outstanding at January 31, 2021	194,417	$3.90


Restricted Stock Units	Number of	Weighted Average
	Shares	Grant Date Fair Value
Outstanding at November 1, 2020	976,180	$2.08

Forfeited	(7,734)	$3.87
Vested	(9,485)	$4.10
Outstanding at January 31, 2021	958,961	$2.04


Stock Options	Number of Shares	Weighted Average Exercise Price	Weighted Average Contractual Life (in years)	Aggregate Intrinsic Value (in thousands)

Outstanding at November 1, 2020	331,944	$5.73	6.22	$—

Outstanding and Exercisable at January 31, 2021	331,944	$5.73	5.97	$—

For the three months ended January 31, 2021, there was no exercise of stock options. As of January 31, 2021, total unrecognized compensation expense of $1.0 million related to PSUs, stock options and RSUs will be recognized over the remaining weighted average vesting period of 1.8 years of which $0.6 million, $0.3 million and $0.1 million are expected to be recognized in fiscal 2021, 2022 and 2023, respectively.